HAL vs MTNB · P/E 9.3, $19.05B cap vs rev $1.1M
Halliburton Company (HAL) versus Matinas BioPharma Holdings Inc (MTNB) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Matinas BioPharma Holdings Inc (MTNB) is a biotechnology company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported MTNB revenue for 2023-12-31 was $1.1M. Net income was -$22.9M. Revenue was down 65.6% from 2022-12-31 to 2023-12-31. MTNB currently screens at market cap $5.6M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. MTNB currently screens at market cap $5.6M.
Not investment advice. Open the HAL and MTNB stock pages for the full models.
Not investment advice.